Combination therapy of proliferative diabetic retinopathy using the Russian biosimilar ranibizumab
Proliferative diabetic retinopathy (PDR) is one of the main causes of vision loss in diabetes mellitus. Panretinal laser photocoagulation (PRP) remains one of the main methods of treating the proliferative process in diabetic retinal damage. In 2018, a prospective randomized multicenter open-label P...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
Real Time Ltd
2025-09-01
|
| Saila: | Российский офтальмологический журнал |
| Gaiak: | |
| Sarrera elektronikoa: | https://roj.igb.ru/jour/article/view/1887 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|